GO
Loading...
 

Say no to Ranbaxy for now: Pro

Tue 04 Feb 14 | 10:25 PM ET
 Highlight transcript below to create clip
Transcript:  Print  |  Email
    This term does not appear
Go
 Click text to jump within video

Say no to Ranbaxy for now: Pro

Tue 04 Feb 14 | 10:25 PM ET
Considering the FDA ban on drugs manufactured at the company¿s Toansa unit, Nitin Agarwal, Analyst at IDFC Securities, says there are too many risks to buy into Ranbaxy shares. The Indian firm is due to release earnings on Wednesday.

Topics:

United States
 
RELATED ARTICLES AND CONTENT
More Videos
Latest Videos
Luxury rental boom ... in Jersey
Fri 18 Apr 14 | 12:00 PM ET
Latest Videos
Great growth expectations
Fri 18 Apr 14 | 11:00 AM ET
Latest Videos
Remodeling & insurance costs
Fri 18 Apr 14 | 09:00 AM ET
Go
Displaying results for: Latest Video | US